title: Do health plans have a role in limiting antibiotic resistance?
authors.forename: Joseph
authors.initials: J
authors.lastname: Burns
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D015373:Bacterial Typing Techniques / Q000379:methods / Q000639:trends; D004352:Drug Resistance, Microbial; D014943:Global Health; D019983:Guideline Adherence; D006801:Humans; D057970:Inappropriate Prescribing / Q000191:economics / Q000517:prevention & control*; D007342:Insurance Benefits / Q000592:standards; D007348:Insurance, Health / Q000191:economics / Q000592:standards*; D055553:Prescription Drugs / Q000191:economics / Q000592:standards* / Q000627:therapeutic use; D012052:Reimbursement, Incentive; D013997:Time Factors; D014481:United States / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D055553:Prescription Drugs